Inibsa Inibsa
Injectable anaesthetics

SCANDINIBSA 3% SOLUTION FOR INJECTION

Provide your patients with extra care and attention with Scandinibsa 3%. With its mild vasodilating effect, mepivacaine can be used without a vasoconstrictor, still offering great performance. Recommended for patients in whom a vasoconstrictor is contraindicated and for dental procedures not requiring lengthy or profound pulpal anaesthesia. 

Brand names: SCANDINIBSA®, MEPIDENTAL®, MEPICART® & SCANDIVIN® 

VIEW ALL
CLOSE ALL

Indications

SCANDINIBSA 3% SOLUTION FOR INJECTION is a local anaesthetic indicated for local and regional anaesthesia in dental procedures for adults, adolescents, and children over 4 years of age (with a body weight of approximately 20 kg).

Benefits
  • Glass cartridges
  • Latex-free plungers and caps
  • Inner and outer silicone coating
  • Plungers compatible with manual and self-aspirating syringes

Duration

ONSET OF ACTION: 3-5 min 

PULPAL ANAESTHESIA: Maxillary infiltration: 25 min; IANB: 40 min

SOFT TISSUE: Maxillary infiltration: 90 min; IANB: 165 min

Composition

Mepivacaine HCI 3%

Each ml contains:

  • Mepivacaine hydrochloride 30.00 mg

Presentation

Boxes of 50 or 100 cartridges of 1.8 ml (subject to market availability), with transparent blisters of 10 cartridges each.

Other names

SCANDINIBSA®, MEPIDENTAL®, MEPICART® & SCANDIVIN®

Uses

Infiltration and perineural use in the oral cavity. For use in dental anaesthesia only.

Single-use cartridges.

 

Other professionals have seen

See all our products

Other professionals have seen

Inibsa

Injectable anaesthetics

SCANDINIBSA 2% 1:100,000 SOLUTION FOR INJECTION

More information of interest

General odontology

Monoprotect® Inibsa PLUS Dental Needles: A new standard in safety and…

26/03/2025

Inibsa launches a new dental needles line: Monoprotect ® Inibsa PLUS.
Inibsa
KEEP READING

General odontology

Safety in the Dental Practice

05/03/2025

Although the dental office is a friendly and welcoming place with people coming and going, it is…
Inibsa
KEEP READING

Interviews

Interview with Natalia Urrecho, Corporate Services Director at Inibsa

27/02/2025

Exclusive Interview with Natalia Urrecho, Corporate Services Director at Inibsa! In this…
Inibsa
KEEP READING

General odontology

Medical Emergencies in the Dental Office

21/01/2025

The combination of exposure to medications, stress, fear, and patient comorbidities may play a role…
Inibsa
KEEP READING

General odontology

Dental Anaesthesia on Patients with Cardiovascular Diseases

16/12/2024

Administering dental anaesthesia to patients with cardiovascular diseases requires careful…
Inibsa
KEEP READING

General odontology

Comparing dental anaesthetic primary packagings

21/11/2024

Local anaesthesia is a fundamental procedure in dental practice, crucial for patient comfort and…
Inibsa
KEEP READING

Interviews

Successful FAT of the new L6 cartridge filling line: a milestone for…

28/10/2024

We spoke to Sergio Rodríguez, a Project and Continuous Improvement Technician, about our latest…
Inibsa
KEEP READING

General odontology

How to stand out in a competitive market: Marketing strategies for…

23/09/2024

Standing out or distinguishing yourself from competitors in such a competitive market is quite a…
Inibsa
KEEP READING

Interviews

Interview with Jordi Gil, Head of Engineering and Maintenance at…

12/09/2024

Discover the recent progress we’ve made in sustainability, the challenges we've overcome, and how…
Inibsa
KEEP READING

General odontology

Is Teledentistry Here to Stay?

28/08/2024

Teledentistry has been available since the 1990s. However, telemedicine services expanded during…
Amanda Jacot, PharmD
KEEP READING